(Q53934663)

22 May 2018

title

Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. (English)

1 reference

22 May 2018

1 reference

1 reference

1 reference

Murthy S

1

1 reference

22 May 2018

Cooper HS

2

1 reference

22 May 2018

Yoshitake H

3

1 reference

22 May 2018

Meyer C

4

1 reference

22 May 2018

Meyer CJ

5

1 reference

22 May 2018

Murthy NS

6

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

22 May 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

22 May 2018

volume

13

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

251-260

1 reference

22 May 2018

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Significance of systemic endotoxaemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Oxpentifylline, tumour necrosis factor-alpha and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00457.X

10.1046/J.1365-2036.1999.00457.X

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018